These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24506698)
1. Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio. Das M; Jain R; Agrawal AK; Thanki K; Jain S Bioconjug Chem; 2014 Mar; 25(3):501-9. PubMed ID: 24506698 [TBL] [Abstract][Full Text] [Related]
2. Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy. Han H; Valdepérez D; Jin Q; Yang B; Li Z; Wu Y; Pelaz B; Parak WJ; Ji J ACS Nano; 2017 Feb; 11(2):1281-1291. PubMed ID: 28071891 [TBL] [Abstract][Full Text] [Related]
3. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy. Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285 [TBL] [Abstract][Full Text] [Related]
4. Stereocomplex Prodrugs of Oligo(lactic acid) Tam YT; Huang C; Poellmann M; Kwon GS ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934 [TBL] [Abstract][Full Text] [Related]
5. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo. Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133 [TBL] [Abstract][Full Text] [Related]
6. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells. Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115 [TBL] [Abstract][Full Text] [Related]
7. Self-Delivery Nanoparticles of Amphiphilic Methotrexate-Gemcitabine Prodrug for Synergistic Combination Chemotherapy via Effect of Deoxyribonucleotide Pools. Wang Y; Huang P; Hu M; Huang W; Zhu X; Yan D Bioconjug Chem; 2016 Nov; 27(11):2722-2733. PubMed ID: 27723981 [TBL] [Abstract][Full Text] [Related]
8. Implication of linker length on cell cytotoxicity, pharmacokinetic and toxicity profile of gemcitabine-docetaxel combinatorial dual drug conjugate. Kushwah V; Katiyar SS; Agrawal AK; Saraf I; Singh IP; Lamprou DA; Gupta RC; Jain S Int J Pharm; 2018 Sep; 548(1):357-374. PubMed ID: 29981409 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment. Xu D; Lu ST; Li YS; Baidya A; Mei H; He Y; Wu B Drug Des Devel Ther; 2018; 12():3301-3309. PubMed ID: 30323562 [TBL] [Abstract][Full Text] [Related]
10. Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine. Cilurzo F; Cristiano MC; Da Pian M; Cianflone E; Quintieri L; Paolino D; Pasut G Anticancer Agents Med Chem; 2019; 19(12):1513-1522. PubMed ID: 31241440 [TBL] [Abstract][Full Text] [Related]
11. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic. Papa AL; Sidiqui A; Balasubramanian SU; Sarangi S; Luchette M; Sengupta S; Harfouche R Cell Oncol (Dordr); 2013 Dec; 36(6):449-57. PubMed ID: 24081907 [TBL] [Abstract][Full Text] [Related]
12. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy. Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247 [TBL] [Abstract][Full Text] [Related]
13. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles. Daman Z; Ostad S; Amini M; Gilani K Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells. Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799 [TBL] [Abstract][Full Text] [Related]
15. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes. Razzazan A; Atyabi F; Kazemi B; Dinarvand R Mater Sci Eng C Mater Biol Appl; 2016 May; 62():614-25. PubMed ID: 26952465 [TBL] [Abstract][Full Text] [Related]
16. Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers. Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Boyd BJ; Owen DJ; Porter CJ Mol Pharm; 2011 Apr; 8(2):338-49. PubMed ID: 21171585 [TBL] [Abstract][Full Text] [Related]
17. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer. Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255 [TBL] [Abstract][Full Text] [Related]
18. Controlled drug release from polyelectrolyte-drug conjugate nanoparticles. Catarata R; Azim N; Bhattacharya S; Zhai L J Mater Chem B; 2020 Apr; 8(14):2887-2894. PubMed ID: 32191246 [TBL] [Abstract][Full Text] [Related]
19. Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate. Chu W; Tian P; Ding N; Cai Q; Li J; Zhuo X; Tang Z; Gou J; Yin T; Zhang Y; He H; Tang X Pharm Res; 2018 Oct; 35(12):230. PubMed ID: 30327887 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system. Yousefi G; Foroutan SM; Zarghi A; Shafaati A Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):147-53. PubMed ID: 20118571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]